Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 2006

View Archived Issues

Glenmark presents new CB2 agonists as promising antihyperalgesic candidates

Silenor effective at inducing and maintaining sleep in transient insomnia patients

Phase I results warrant abagovomab's further evaluation

GPCR inhibitor blocks cancer growth, induces apoptosis and synergizes with anticancer drugs

Sazetidine-A: a new desensitizing nicotinic ligand

Recent patents report new treatment strategies for respiratory disorders

Therapeutic agents for arteriosclerosis, hypertension, etc. disclosed in recent patents

Recent patent literature discloses novel analgesic agents

Orexo receives license payment from Endo for Rapinyl

Acadia to support new substance abuse startup company Abbey

Enrollment over half complete in phase IIb trial of CF-101 in rheumatoid arthritis

Phase II study of HCV-796 begins dosing

Preliminary three-month findings from endometriosis study of Proellex

MVA-BN polytope vaccine begins new trials in Europe

New trial studies HuMax-EGFr with chemoradiation for head and neck cancer

Dharma's iontophoretic drug delivery system shows promise in phase I study

EvoGenix completes first project under GSK collaboration

ASF-1057 begins phase IIb studies for seborrheic dermatitis

Alantos and Servier collaborate on DPP-IV inhibitor ALS-2-0426

Amgen completes acquisition of Avidia

Termination of Takeda and BioNumerik's Tavocept agreement

Renovo: pipeline update

Aridol approved in Sweden

FDA approves Tyzeka for chronic hepatitis B

Promising preliminary results for ASF-1096 formulation in cutaneous lupus erythematosus

New clinical study of levetiracetam for Tourette syndrome

Memory Pharmaceuticals discloses MEM-3454 preclinical data at the SfN meeting

The glycine transporter-1 inhibitor SSR-103800 shows promise in animal models of schizophrenia

Targeting Fc receptors: a promising approach for the treatment of B-cell malignancies

Mahonia aquifolium alkaloids may be useful against Malassezia skin infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...